The DEA Wants 7-OH in Schedule I. Nobody Has Said What Happens to the People Taking It Today.
Two Mississippi students are dead, 36,000 comments are in, and the plan for dependent users is still blank.
Two University of Mississippi students died in September with synthetic kratom products found at the scene, STAT reported on September 30, and their deaths are now part of the argument over what the federal government does next.
Scheduling a drug does not schedule the people who are already dependent on it.
7-OH is short for 7-hydroxymitragynine, a compound that occurs in trace amounts in kratom leaf and shows up in much higher concentrations in some products sold at gas stations and smoke shops. On July 6, the DEA published a notice of intent to place 7-OH above set concentration thresholds, plus three related substances, temporarily into Schedule I, the DEA’s most restrictive category. The plant itself and low-7-OH products are outside the notice. Per the notice, HHS has concluded these substances have no accepted medical use and a high potential for abuse. The comment period closed September 10 with nearly 36,000 submissions, and in late August Massachusetts imposed a temporary statewide ban on all kratom products.
Nobody in STAT’s reporting argues the concentrated products are harmless. The split is over the tool. Andrew Herring, chief of addiction medicine at Alameda Health System, put his position in three words: “Make it illegal.” Katherine Hill, an epidemiology doctoral candidate at the Yale School of Public Health, said “to go all the way to scheduling seems very extreme to me.” Regina LaBelle, who teaches addiction policy at Georgetown, named the structural problem: “Often, the only tool we have in our tool belt is scheduling.” Critics quoted in the story warn that a ban can push dependent users into withdrawal or toward more dangerous substances, and that it invites whack-a-mole as chemists invent the next variant. About 24 states have passed consumer-protection laws that mostly set age limits, which STAT’s sources describe as uneven. Utah’s licensing and testing regime is the strictest model on offer.
Name the gate: a temporary order does not take effect until the DEA publishes it, and what happens at the counter depends on that date and on state law. For providers, the useful move is this week’s intake form. Add one question, kratom or 7-OH, how much, how often, and decide with your prescriber now, not after the order lands, what you will do for a person who walks in already in withdrawal.
If you take it daily, the thing to hear is that withdrawal from a regular habit is real and medical help exists. Talk to a clinician before you stop, or call the free SAMHSA National Helpline at 1-800-662-4357, any hour.
The law will arrive on a date. The withdrawal will arrive on a morning.
Sources Cited
- 01.B
- 02.A
Filed Under
policyharm-reductionKratomDEADrug Scheduling
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
If Someone Stays Under After Naloxone, the Supply Changed. Medetomidine Is Why.
Medetomidine has replaced xylazine in the fentanyl supply, according to 2026 lab data. Naloxone does not reverse it, and its withdrawal can look like a cardiac emergency.
Harm ReductionA Blister Pack That Looks Like Xanax Is Now Linked to Several Overdoses in Dublin
A new, unnamed benzodiazepine stronger than Valium or Xanax is linked to overdoses in Dublin, sold in blister packs that look legitimate. What it means for anyone who relies on a pill's packaging.
Harm ReductionSomeone in Tasmania Died After Using Drugs That May Have Held an Opioid They Didn't Know About
Tasmania's health department reports a death possibly involving a rare synthetic opioid from the 'U-class', the first known detection in the state. Why the warning applies to anyone who uses anything.